Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Dotmatics Informatics Selected to Enhance Research at Moulder Center for Drug Discovery

Published: Friday, January 25, 2013
Last Updated: Friday, January 25, 2013
Bookmark and Share
The Dotmatics platform is an integrated suite of software specifically designed to maximise efficiency in data transfer between research institutes, collaborators and CROs.

"After a thorough review of the commercially available software packages for sharing and exploiting the fruits of drug discovery research, it became clear that the Dotmatics platform represented not only the best configuration, but also the most comprehensive package available" said Dr. Magid Abou-Gharbia, Associate Dean for Research and Director of the Moulder Center. "In building our capacity at the Moulder Center for Drug Discovery Research we are focused on efficiently generating research data using a host of technologies and tools. The combination of Browser, Vortex and StudiesNotebook are key solutions which will allow our scientists to quickly triage, integrate and analyze data from multiple sources, speeding the pace and efficiency of research. These advantages afford our scientists increased opportunity to improve the health of patients through the discovery of new therapeutic agents."

The migration of The Moulder Center for Drug Discovery Research's legacy database to the Dotmatics platform will have a positive and dramatic impact on research workflow. Dr. Abou-Gharbia continued “Researchers at our center will benefit from the advanced data querying, analysis and reporting tools provided by this high end informatics platform. In addition, the secure web-based deployment of Dotmatics software will allow our external collaborators to easily access their data while maintaining safeguards against the release of data from unrelated programs. Our adoption of the Dotmatics system provides The Moulder Center with cutting edge Cheminformatics and database capabilities.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More Than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Dotmatics Joins Pistoia Alliance
Dotmatics becomes member of Alliance which seeks to define the future of Life Sciences R&D information management.
Monday, March 02, 2015
Dr Tom Oldfield Joins Dotmatics as Principal Software Architect
Appointment of renowned technologist strengthens company position in big data analytics and biology.
Wednesday, January 28, 2015
The TDDG Selects Dotmatics Data Management Suite
University of Sussex has selected Dotmatics’ web-based Electronic Laboratory Notebook, Studies Notebook
Monday, January 27, 2014
Dotmatics Teams with Leading Distributor to Launch Life Science Informatics Platform in China
The partnership will make Dotmatics’ versatile informatics platform available to a large new market and will provide local support to Dotmatics’ existing Chinese customer base.
Tuesday, March 05, 2013
Dotmatics Vortex Selected to Boost Drug Discovery Efforts at The University of Leeds
Dotmatics announced that it has deployed Vortex for data analysis and visualisation at the University of Leeds, UK.
Tuesday, February 12, 2013
The Dotmatics Enterprise Platform is Licensed by Redx Pharma
Deployment aids quest to develop new drug candidates.
Thursday, January 31, 2013
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Self-Propelled Powder to Stop Bleeding
UBC researchers have created the first self-propelled particles capable of delivering coagulants against the flow of blood to treat severe bleeding, a potentially huge advancement in trauma care.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Probing the Forces Involved in Creating The Mitotic Spindle
Scientists at The Rockefeller University reveal new insights into the mechanical forces that govern elements of the mitotic spindle formation.
Identifying Cancer’s Food Sensors May Help to Halt Tumour Growth
Oxford University researchers have identified a protein used by tumours to help them detect food supplies. Initial studies show that targeting the protein could restrict cancerous cells’ ability to grow.
Fatty Liver Disease and Scarring Have Strong Genetic Component
Researchers say that hepatic fibrosis, which involves scarring of the liver that can result in dysfunction and, in severe cases, cirrhosis and cancer, may be as much a consequence of genetics as environmental factors.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos